-
-
-
-
-
-
-
Seagen (SGEN) Announces TUKYSAin Combination with Trastuzumab Granted Priority Review by FDA for Previously Treated HER2-Positive Metastatic Colorectal Cancer
-
-
-
-
-
-
-
Seattle Genetics Reports Second Quarter 2020 Financial Results
-
-
-
-
-
-
-
Seattle Genetics Reports Third Quarter 2019 Financial Results
-
-
-
-
-
-
-
Seattle Genetics Reports Fourth Quarter and Year 2017 Financial Results
-
-
-
-
-
-
-
Seattle Genetics (SGEN) Submits sBLA to FDA for ADCETRIS in Frontline Advanced Hodgkin Lymphoma
-
-
-
-
-
-
-
Pre-Open Movers 10/02: (RIGL) (SNCR) (TRN) Higher; (JWN) (GNW) (ROKU) Lower (more...)
-
-
-
-
-
-
12,339 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All